K-pop

Cheongha Recovers Just One Day After Being Taken to the Emergency Room… "I'll Be on Stage Today"

Cheongha Was Taken to the Emergency Room on the 18th and Received Treatment Kyunggi University Cancels 'Gwi-ryong Festival' Stage Performances

Gim Ga Yeong
2026-09-19 17:52:16
[Edaily Starin Gim Ga Yeong Reporter] Singer Chungha, who was taken to the emergency room due to health issues, is resuming her schedule after recovering.
Cheongha (Photo courtesy of More Vision)
A representative from her agency, More Vision, stated on the 19th, “Cheongha will attend the ‘KB Joy Olpark Festival 2026’ taking place today at the 88 Lawn Plaza in Seoul Olympic Park.”
Previously, on the 18th, Cheongha was taken to the emergency room due to health issues and received treatment. She had originally been scheduled to perform at the “Gwryongje” festival at Kyunggi University’s Seoul Campus that day, but her appearance was canceled due to her health condition.
The agency stated, “We sincerely apologize to the Kyunggi University officials and students who were looking forward to the performance for causing concern and inconvenience with this sudden news,” adding, “We will do our best to ensure the artist recovers her health as soon as possible.”
Meanwhile, Cheongha released her new song “Mexico” on the 1st and is continuing her comeback activities.

Economy

Corporation

IT·Science

Economy

[VC's Pick] The AI That Played a Match Against Lee Sedol 9-dan… Enhance Secures 51.2 Billion Investment

This week (September 14–18), startups in various fields—including medical artificial intelligence (AI), content solutions, and content tech—secured investments from venture capital (VC) firms and acce…
2026-09-19 09:21:04

Corporation

Kang Seong-min, CEO of PeopleBio, Inc.: “Full-Scale Launch of LDT and Diagnostic Kit Business in the U.S. … Revenue to Become Apparent Starting Next Year”

“Building on our designation as an innovative medical device by the U.S. Food and Drug Administration (FDA), we plan to establish a local subsidiary within this year. Next year, we will launch laborat…
2026-09-19 08:07:02

IT·Science

Opacalim Clinical Trials Paused… A Closer Look at the Preconditions for SK BIOPHARMACEUTICALS’s 2.3 Trillion Won Deal

SK BIOPHARMACEUTICALS(326030)has drawn attention by repeatedly emphasizing that the deal to acquire “Opacalym” (BHV-7000), a new drug candidate for epilepsy, from the U.S. biotech company Biohaven is …
2026-09-19 08:41:01